维普中文期刊产品整合服务
207篇 您的检索式:作者名="KLOTZ L"
    题名 作者 年代 出处 被引量
1A re-assessment of the role of combined androgen blockade for advanced prostate cancer 显示文摘Klotz L Schellhammer P Carroll K 2004BJU Int2004,93,:1
2Active surveillance for favorablerisk prostate cancer=a short review显示文摘Lawrentschuk N Klotz L 2010Korean J Urol2010,51,0:1
3Final results of the Canadian prospective phase Ⅱ trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for loeally advanced prostate cancer: clinical parameters显示文摘Bruchovsky N Klotz L Crook J 2006Cancer2006,107,2:1
4Poly (ethylenimines)with Alternative (Alkylamino)pyridines as Nucleophilic Catalysts显示文摘Delaney E J Wood L E Klotz I M 1982J Am Chem Soc1982,,104:1
5Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state显示文摘McCullough K D Martindale J L Klotz L O 2001Mol Cell Biol2001,21,4:1
6Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2and perturbing the cellular redox state显示文摘Mc Cullough K D Martindale J L Klotz L O 2001Molecular and Cellular Biology2001,21,:1
7Personal contact,individuation,and the better-than-average effect显示文摘Alicke M D Klotz M L Breitenbecher D L 1995Journal of Personality&Social Psychology1995,68,5:1
8Locally advanced prostate cancer: biochemical results from a prospeelive phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy显示文摘Bruehovsky N Klotz L Crook J 2007Cancer2007,109,5:1
9Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer显示文摘Hall SJ Klotz L Pantuck AJ 2011J Urol2011,186,3:1
10Peroxisome proliferator- activated receptor gamma control of dendritic cell function contributes to development of CD4 + T cell anergy 显示文摘Klotz L Dani I Edenhofer F 2007JIm-munol2007,178,4:1
11Thermodynamic assessment of the Sn-Ti system显示文摘Liu C L Klotz U E Uggowitzer P J 2005Monatsh far Chem/ Chem Monthly2005,136,11:1
12Cancer overdiagnosis and overtreatment 显示文摘Klotz L 2012Curr Opin Urol2012,22,3:1
13The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-abel, parallel- group phase Ill study in patients with prostate cancer 显示文摘Klotz L Boccon-Gibod L Shore ND 2008BJU Int2008,102,11:1
14Reactive oxygen spe- cies (ROS-induced) ROS release: a new phenomenon accompa- nying induction of the mitochondrial permeability transition in cardiac myocytes显示文摘Zorov D B Filburn C R Klotz L O 2000Exp Med2000,192,:1
15Linking Alzheimer\'s disease to insulin resistance: the FoxO response to oxidative stress显示文摘Manolopoulos K N Klotz L O Korsten P 2010Mol Psyc Hiatry2010,15,11:1
16Personal contact,individuation,and the better-thanaverage effect显示文摘 Klotz M L Breitenbecher D L 1995Journal of Personality and Social Psychology1995,68,:1
17Maximal androgen blockade for advanced prostate cancer显示文摘Klotz L 2008Best Pract Res Clin Endocrinol Metab2008,22,2:1
18Phytohormone control of the tobacoo anionic peroxidase promoter显示文摘KLOTZ K L LAGRIMINI L M 1996Plant Mol Biol1996,31,:1
19The efficacy and safety of degareliv:a 12-month,comparative,randomized,open-label,parallel-group phase Ⅲ study in patients with prostate cancer显示文摘KLOTZ L boccon-GIBOD L SHORE N D 2008BJU Int2008,502,11:1
20Peroxisome prolifera-tor-activated receptor gamma control of dendritic ceil function contributes to development of CD4 + T cell energy显示文摘Klotz L Dani L Edenhofer F 2007J Immunol2007,178,4:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费